A/O new/O drug/O to/O prevent/O the/O rejection/O of/O transplanted/O organs/O has/O been/O successfully/O used/O on/O more/O than/O 100/O patients/O at/O the/B-ORG University/I-ORG of/I-ORG Pittsburgh/I-ORG ,/O according/O to/O researchers/O ./O
The/O drug/O ,/O which/O is/O still/O in/O the/O experimental/O phase/O ,/O has/O n't/O been/O approved/O yet/O by/O the/B-ORG Food/I-ORG and/I-ORG Drug/I-ORG Admistration/I-ORG ,/O and/O its/O long/O -/O term/O effects/O are/O unknown/O ./O
But/O researchers/O say/O the/O drug/O ,/O called/O FK/O -/O 506/O ,/O could/O revolutionize/O the/O transplantation/O field/O by/O reducing/O harmful/O side/O effects/O and/O by/O lowering/O rejection/O rates/O ./O
Rejection/O has/O been/O the/O major/O obstacle/O in/O the/O approximately/O 30,000/O organ/O transplants/O performed/O world/O -/O wide/O each/O year/O ./O
Researchers/O began/O using/O the/O drug/O in/O February/O on/O patients/O who/O had/O received/O kidney/O ,/O liver/O ,/O heart/O and/O pancreas/O transplants/O ./O
Only/O two/O of/O 111/O transplants/O have/O been/O rejected/O ./O
The/O drug/O ,/O discovered/O in/O 1984/O ,/O is/O metabolized/O from/O soil/O fungus/O found/O in/O Japan/B-GPE ./O
The/O Pittsburgh/B-GPE patients/O are/O the/O first/O humans/O to/O be/O given/O the/O drug/O ,/O which/O is/O made/O by/O Fujisawa/B-ORG Pharmaceutical/I-ORG Co/I-ORG ./O
``/O We/O 're/O shocked/O by/O it/O ,/O because/O it/O 's/O worked/O so/O fast/O ,/O ''/O said/O Dr./O Thomas/B-PERSON E./I-PERSON Starzl/I-PERSON ,/O director/O of/O the/B-ORG University/I-ORG of/I-ORG Pittsburgh/I-ORG Transplantation/I-ORG Program/I-ORG ,/O at/O a/O news/O conference/O here/O yesterday/O ./O
``/O We/O consider/O it/O a/O life/O -/O saving/O drug/O ,/O like/O one/O for/O AIDS/O ,/O ''/O said/O Dr./O John/B-PERSON Fung/I-PERSON ,/O an/O immunologist/O at/O the/B-ORG University/I-ORG of/I-ORG Pittsburgh/I-ORG ./O
Researchers/O say/O they/O believe/O FK/O -/O 506/O is/O 100/O times/O more/O effective/O than/O the/O traditional/O anti-rejection/O drug/O ,/O cyclosporine/O ,/O made/O by/O Swiss/O pharmaceutical/O giant/O Sandoz/B-ORG Ltd/I-ORG ./O
They/O are/O also/O encouraged/O by/O the/O relatively/O mild/O side/O effects/O of/O FK/O -/O 506/O ,/O compared/O with/O cyclosporine/O ,/O which/O can/O cause/O renal/O failure/O ,/O morbidity/O ,/O nausea/O and/O other/O problems/O ./O
``/O The/O side/O effects/O -LCB-/O of/O cyclosporine/O -RCB-/O have/O made/O the/O penalty/O for/O its/O success/O rather/O high/O ,/O ''/O Dr./O Starzl/B-PERSON said/O ./O
Dr./O Fung/B-PERSON said/O that/O FK/O -/O 506/O would/O not/O be/O available/O in/O the/O market/O for/O at/O least/O a/O year/O ,/O and/O that/O the/O FDA/B-ORG approval/O process/O usually/O takes/O three/O years/O to/O five/O years/O ./O
There/O are/O no/O firm/O plans/O to/O expand/O the/O experimental/O program/O beyond/O the/B-ORG University/I-ORG of/I-ORG Pittsburgh/I-ORG ,/O whose/O hospital/O performs/O the/O most/O transplants/O in/O the/O world/O ./O
Researchers/O could/O n't/O estimate/O the/O cost/O of/O the/O drug/O when/O it/O reaches/O the/O market/O ,/O but/O they/O said/O FK/O -/O 506/O will/O enable/O patients/O to/O cut/O hospital/O stays/O by/O 50/O %/O and/O reduce/O the/O number/O of/O blood/O tests/O used/O to/O monitor/O the/O dosage/O of/O cyclosporine/O and/O other/O drugs/O among/O transplant/O recipients/O ./O
Dr./O Starzl/B-PERSON said/O the/O research/O has/O been/O largely/O financed/O by/O the/B-ORG National/I-ORG Institute/I-ORG of/I-ORG Health/I-ORG and/O by/O university/O funds/O ,/O and/O that/O Fujisawa/B-ORG did/O n't/O give/O the/O hospital/O any/O grants/O ./O
He/O said/O that/O the/O research/O team/O had/O no/O financial/O stake/O in/O the/O drug/O ./O
``/O We/O 've/O known/O for/O six/O months/O the/O effect/O of/O this/O drug/O ,/O and/O our/O advice/O to/O our/O people/O has/O been/O not/O to/O buy/O the/O company/O 's/O stock/O ,/O ''/O Dr./O Starzl/B-PERSON said/O ,/O adding/O that/O profiting/O from/O FK/O -/O 506/O would/O n't/O be/O ethical/O ./O
